| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2017 | A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio | Chien, MH; Lee, WJ; Chang, YC; Chang, WM; Lai, TC; Chan, DV; Sharma, R; Lin, YF; Hsiao, M | Molecular Cancer Therapeutics 16(6), 1102-1113 | | | |
| 2021 | Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts | Li, LJ; Chang, WM; Hsiao, M | PHARMACEUTICALS 14(3), 194 | | | |
| 2019 | AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway | Chang, WM; Chang, YC; Yang, YC; Lin, SK; Chang, MH; Hsiao, M | Journal of Experimental & Clinical Research 38, 245 | | | |
| 2020 | Circulating proteoglycan endocan mediates EGFR-driven progression of non-small cell lung cancer | Yang, YC; Pan, KF; Lee, WJ; Chang, JH; Tan, P; Gu, CC; Chang, WM; Yang, SF; Hsiao, M ; Hua, KT; Chien, MM | Cancer Research 80(16), 3292-3304 | | | |
| 2022 | Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling | Li, LJ; Li, CH; Chang, PM; Lai, TC; Yong, CY; Feng, SW; Hsiao, M ; Chang, WM; Huang, CYF | FRONTIERS IN ONCOLOGY 12, 775541 | | | |
| 2014 | Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b. | Shiah, SG; Hsiao, JR; Chang, WM; Chen, YW; Jin, YT; Wong, TY; Huang, JS; Tsai, ST; Hsu, YM; Chou, ST; Yen, YC; Jiang, SS; Shieh, YS; Chang, IS; Hsiao, M; Chang, JY | Cancer Res 74(24), 7560-7572 | | | |
| 2016 | Dysregulation of Runx2/Activin A axis upon miR376c downregulation promotes lymph node metastasis in head and neck squamous cell carcinoma. | Chang, WM; Lin, YF; Su, CY; Peng, HY; Chang, YC; Lai, TC; Wu, GH; Hsu, YM; Chi, LH; Hsiao, JR; Chen, CL; Chang, JY; Shieh, YS; Hsiao, M; Shiah, SG | Cancer Research 76(24):7140-7150 | | | |
| 2022 | FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis | Li, LJ; Chang, PM; Li, CH; Lai, TC; Chang, YC; Su, CY; Chen, CL; Chang, WM; Hsiao, M ; Fung, SW | CELL DEATH DISCOVERY 8, 101 | | | |
| 2017 | Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma | Chi, LH; Chang, YC; Chang, WM; Chan, YC; Tai, CC; Leung, KW; Chen, CL; Wu, ATH; Lai, TC; Li, YCJ; Hsiao, M | Scientific Reports 7, 9031 | | | |
| 2016 | IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma | Peng, HY; Jiang, SS; Hsiao, JR; Hsiao, M ; Hsu, YM; Wu, GH; Chang, WM; Chang, JY; Jin, SC; Shiah, SG | Molecular Oncology 10(6), 895-909 | | | |
| 2017 | Parathyroid hormone-like hormone is a poor prognosis marker of head and neck cancer and promotes cell growth via RUNX2 regulation | Chang, WM; Lin, YF; Su, CY; Peng, HY; Chang, YC; Hsiao, JR; Chen, CL; Chang, JY; Shieh, YS; Hsiao, M; Shiah, SG | Scientific Reports 7, 41131 | | | |
| 2021 | Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma | Yang, YC; Chien, MH; Lai, TC; Tung, MC; Jan, YH; Chang, WM; Jung, SM; Chen, MH; Yeh, CN; Hsiao, M | JOURNAL OF BIOMEDICAL SCIENCE 28, 29 | | | |
| 2003 | Retaining of the assembly capability of vimentin phosphorylated by mitogen-activated protein kinase-activated protein kinase-2. | Cheng, TJ; Tseng, YF; Chang, WM; Chang, MD; Lai, YK | Journal of cellular biochemistry 89(3), 589-602 | | | |
| 2022 | The Aberrant Cancer Metabolic Gene Carbohydrate Sulfotransferase 11 Promotes Non-small Cell Lung Cancer Cell Metastasis via Dysregulation of Ceruloplasmin and Intracellular Iron Balance | Chang, WM; Li, LJ; Chiu, IA; Lai, TC; Chang, YC; Tsai, HF; Yang, CJ; Huang, MS; Su, CY; Lai, TL; Jan, YH; Hsiao, M | TRANSLATIONAL ONCOLOGY 25, 101508 | | | |
